BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cha JH, Jang JS. Correlation between healing type of lesion and recurrence in gastric neoplastic lesions after endoscopic submucosal dissection. Turk J Gastroenterol 2020;31:36-41. [PMID: 32009612 DOI: 10.5152/tjg.2020.18764] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Fang X, Xu J, Jin K, Qian J. Combining of immunotherapeutic approaches with chemotherapy for treatment of gastric cancer: Achievements and limitations. Int Immunopharmacol 2023;118:110062. [PMID: 36965367 DOI: 10.1016/j.intimp.2023.110062] [Reference Citation Analysis]
2 Zhao H, Ding Y, Zhang L. SIRT1/APE1 promotes the viability of gastric cancer cells by inhibiting p53 to suppress ferroptosis. Open Med (Wars) 2023;18:20220620. [PMID: 36820068 DOI: 10.1515/med-2022-0620] [Reference Citation Analysis]
3 Kim DH. Is a Biopsy Required for All Ulcer Scars after Endoscopic Submucosal Dissection of Gastric Neoplasia? Korean J Helicobacter Up Gastrointest Res 2021;21:1-3. [DOI: 10.7704/kjhugr.2020.0066] [Reference Citation Analysis]
4 Sexton RE, Al Hallak MN, Diab M, Azmi AS. Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev 2020;39:1179-203. [PMID: 32894370 DOI: 10.1007/s10555-020-09925-3] [Cited by in Crossref: 95] [Cited by in F6Publishing: 83] [Article Influence: 31.7] [Reference Citation Analysis]